Lenalidomide Impurity B is a degradation byproduct formed via oxidative cleavage of the phthalimide core in lenalidomide, retaining the indole heterocycle but featuring a hydroxyl-substituted benzyl ester moiety. Its structure incorporates a 6-(2-amino-4-methyl-1-oxo-1H-pyrimidin-5-yl) group linked to a 2-(hydroxycarbonyl)benzoic acid ester, differing from the parent compound by a demethylated phthalimide ring and an oxidized side chain. This impurity serves as a critical HPLC reference standard for quantifying oxidative degradation pathways in lenalidomide formulations.
On RequestC1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3[N+](=O)[O-]
InChI=1S/C13H11N3O5/c17-11-5-4-10(12(18)14-11)15-6-8-7(13(15)19)2-1-3-9(8)16(20)21/h1-3,10H,4-6H2,(H,14,17,18)
JKPJLYIGKKDZDT-UHFFFAOYSA-N